Aquestive Therapeutics Filed For Resale Of Up To 2.75M Shares Of Common Stock By The Selling Stockholder
Portfolio Pulse from Charles Gross
Aquestive Therapeutics has filed for the resale of up to 2.75 million shares of common stock by the selling stockholder.
September 21, 2023 | 10:03 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aquestive Therapeutics has filed for the resale of up to 2.75 million shares of common stock. This could potentially dilute the value of existing shares.
The filing for resale of up to 2.75 million shares by Aquestive Therapeutics could lead to a dilution of the value of existing shares, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100